H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance-Reference-Cited by-同舟云学术

H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance

Published:2017-01-19 Issue:1 Volume:8 Page:e2569-e2569
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Peng Fei,Li Ting-Ting,Wang Kai-Li,Xiao Guo-Qing,Wang Ju-Hong,Zhao Hai-Dong,Kang Zhi-Jie,Fan Wen-Jun,Zhu Li-Li,Li Mei,Cui Bai,Zheng Fei-Meng,Wang Hong-Jiang,Lam Eric W-F,Wang Bo,Xu Jie,Liu Quentin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2016438.pdf

Reference50 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.

2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.

3. Filipova A, Seifrtova M, Mokry J, Dvorak J, Rezacova M, Filip S et al. Breast cancer and cancer stem cells: a mini-review. Tumori 2014; 100: 363–369.

4. Gianni L, Baselga J, Eiermann W, Porta VG, Semiglazov V, Lluch A et al. Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. J Clin Oncol 2009; 27: 2474–2481.

5. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Peto R Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Davies C Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Godwin J Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Gray R Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Pan HC et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 2012; 379: 432–444.

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction: H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance;Cell Death & Disease;2024-08-27

2. The role of Lin28A and Lin28B in cancer beyond Let‐7;FEBS Letters;2024-08-16

3. Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development;Heliyon;2024-08

4. hnRNP Q/SYNCRIP interacts with LIN28B and modulates the LIN28B/let-7 axis in human hepatoma cells;PLOS ONE;2024-07-08

5. Novel sex-biased outcomes in neuroblastoma are associated with distinct gene expression and chromosomal loss patterns;2024-06-17